The issue: Erythromycin 333 mg SR oral tablets (ERYC®) have been discontinued in Canada, and there are no other solid oral erythromycin dosage forms currently available. NH has low stock remaining.
Newsroom
COVID-19 testing performed on ID NOW instruments in emergency rooms across NHA has been permanently discontinued, effective immediately.
March 2023 formulary update - effective March 24, 2023
Included in the update:
NH laboratory services is investigating making revisions to the Drugs of Abuse (DOA) test panels offered in our region, and are seeking stakeholder feedback.
The issue: Methotrimeprazine 25 mg/mL x 1 mL injectable is available but still in short supply. NH pharmacy is able to access stock on a weekly basis, but it may not be enough to meet local demand.
The issue: Several pediatric oral antibiotic suspensions remain on shortage in Canada, but NH supply has improved with intermittent stock available for pharmacies to order. NH pharmacy continues to monitor supply closely due to continued instability in the supply chain.
The issue: Calcitonin 200 units/mL X 2 mL injectable remains on backorder from the only manufacturer in Canada, with an estimated resupply date pushed out to August 2023.This is a low use item in NH, but there will likely be a supply gap of several months leading up to the resupp